Kim CG, Hong MH, Kim D, Lee BH, et al. A phase II open-label randomized clinical trial of preoperative durvalumab or durvalumab plus tremelimumab in resectable head and neck squamous cell carcinoma. Clin Cancer Res 2024 Mar 8. doi: 10.1158/1078-0432.CCR-23-3249.
PMID: 38457288